National Bank of Canada’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2
| Closed | -$60 | – | 2650 |
|
|
2024
Q4 | $60 | Sell |
2
-45
| -96% | -$1.35K | ﹤0.01% | 2440 |
|
|
2024
Q3 | $735 | Buy |
+47
| New | +$735 | ﹤0.01% | 2268 |
|
|
2024
Q2 | – | Sell |
-233,000
| Closed | -$3.84M | – | 2593 |
|
|
2024
Q1 | $3.84M | Buy |
+233,000
| New | +$3.84M | 0.01% | 739 |
|
|
2023
Q4 | – | Sell |
-200
| Closed | -$3.09K | – | 2611 |
|
|
2023
Q3 | $3.09K | Hold |
200
| – | – | ﹤0.01% | 2222 |
|
|
2023
Q2 | $8.29K | Sell |
200
-327
| -62% | -$13.6K | ﹤0.01% | 2062 |
|
|
2023
Q1 | $31.7K | Sell |
527
-5
| -0.9% | -$301 | ﹤0.01% | 1714 |
|
|
2022
Q4 | $39K | Buy |
532
+15
| +3% | +$1.1K | ﹤0.01% | 1654 |
|
|
2022
Q3 | $39K | Hold |
517
| – | – | ﹤0.01% | 1618 |
|
|
2022
Q2 | $36K | Buy |
517
+34
| +7% | +$2.37K | ﹤0.01% | 1667 |
|
|
2022
Q1 | $40K | Hold |
483
| – | – | ﹤0.01% | 1720 |
|
|
2021
Q4 | $36K | Buy |
+483
| New | +$36K | ﹤0.01% | 1765 |
|